Prothena Corporation plc (PRTA)
NASDAQ·Healthcare·Biotechnology
$8.63
+4.10%
Mkt Cap $431.91M
Analyst Ratings
No recent rating data.
Price Target (14 analysts)
$19.00
Range $19.00 – $19.00
Implied Upside
+120.2%
Consensus $19.00 vs current $8.63
NASDAQ·Healthcare·Biotechnology
$8.63
+4.10%
Mkt Cap $431.91M
No recent rating data.
Price Target (14 analysts)
$19.00
Range $19.00 – $19.00
+120.2%
Consensus $19.00 vs current $8.63